[EN] SUBSTITUTED HETEROCYCLIC ETHERS AND THEIR USE IN CNS DISORDERS<br/>[FR] ETHERS HÉTÉROCYCLIQUES SUBSTITUÉS ET LEUR UTILISATION DANS DES TROUBLES DU SNC
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2009009633A1
公开(公告)日:2009-01-15
The invention encompasses compounds of Formula I, including pharmaceutically acceptable salts, their pharmaceutical compositions, and their use in treating CNS disorders.
该发明涵盖了I式化合物,包括药学上可接受的盐,它们的药物组合物以及它们在治疗中枢神经系统疾病中的用途。